SCHEMBL3148134

SCHEMBL3148134

CCCCCCCCC(C)(C)OC

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
THRB P10828 1/20 0.42
GGPS1 O95749 6/20 0.38
SMPD1 P17405 3/20 0.38
SPHK2 Q9NRA0 1/20 0.37
FDPS P14324 9/20 0.37
EPHX1 P07099 1/20 0.37
CES2 O00748 1/20 0.35
LPAR1 Q92633 1/20 0.35
LPAR3 Q9UBY5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11355071 1.00 TSHR (0.46) TSHRALDH1A1TDP1THRBGGPS1
SCHEMBL95578 1.00 TSHR (0.46) TSHRALDH1A1TDP1THRBGGPS1
SCHEMBL3169691 0.97 TSHR (0.48) TSHRALDH1A1TDP1THRBGGPS1
SCHEMBL763414 0.89
SCHEMBL20299935 0.81 TSHR (0.44) TSHRTHRBGGPS1SMPD1FDPS
SCHEMBL9576868 0.81 TSHR (0.44) TSHRTHRBGGPS1SMPD1FDPS
SCHEMBL7208110 0.81 TSHR (0.44) TSHRTHRBGGPS1SMPD1FDPS
SCHEMBL20299931 0.81 TSHR (0.44) TSHRTHRBGGPS1SMPD1FDPS
SCHEMBL6658765 0.81 TSHR (0.44) TSHRTHRBGGPS1SMPD1FDPS
SCHEMBL11699499 0.81 TSHR (0.44) TSHRTHRBGGPS1SMPD1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110256418-A The benzamide that 1,3- thiazol-2-yl replaces 拜耳公司 2019-09-20 CN disclosed
CN-109111430-A A kind of Dexlansoprazole crystal form A and preparation method thereof 江苏豪森药业集团有限公司 2019-01-01 CN disclosed
CN-107207507-A 1, 3-thiazol-2-yl substituted benzamides 拜耳公司 2017-09-26 CN disclosed
US-8212046-B2 Process for producing crystal TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-07-03 US disclosed
US-20100004458-A1 PROCESS FOR PRODUCING CRYSTAL TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-07 US disclosed
CN-100562318-C Crystalline preparation method TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2009-11-25 CN disclosed
US-7569696-B2 Process for producing crystal TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-08-04 US disclosed
US-20080306118-A1 Process for the crystallization of (R) - or (S) - Lansoprazole TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 US disclosed
US-7285668-B2 Process for the crystallization of (R)- or (S)-lansoprazole TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-10-23 US disclosed
US-7169799-B2 Process for producing crystal TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-30 US disclosed
US-20070004779-A1 Process for producing crystal HASHIMOTO HIDEO 2007-01-04 US disclosed
CN-1280287-C Method for producing crystal TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2006-10-18 CN disclosed
CN-1803137-A Process for producing crystal TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2006-07-19 CN disclosed
US-20040049045-A1 Process for the crystallization of (r)-or (s)-lansoprazole TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
CN-1437592-A Method for producing crystal TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-08-20 CN disclosed
US-20030153766-A1 Process for producing crystal TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-08-14 US disclosed
CN-1081675-A By the new pyrethroid of thiazolic alcohol derivative, its preparation method and as the purposes of agricultural chemicals ROUSSEL UCLAF (FR) 1994-02-09 CN disclosed